Hemodialysis

Rockwell Medical, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

Retrieved on: 
Thursday, March 4, 2021
Membrane technology, Medicine, Natural sciences, Physical sciences, Rockwell Medical, Hemodialysis, Dialysis, Iron(III) pyrophosphate

Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU, are the only FDA-approved therapeutics indicated for maintenance of hemoglobin in hemodialysis patients.

Key Points: 
  • Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU, are the only FDA-approved therapeutics indicated for maintenance of hemoglobin in hemodialysis patients.
  • Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.
  • Triferic is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office.
  • All other product names, logos, and brands are property of their respective owners in the United States and/or other countries.

VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients

Retrieved on: 
Tuesday, February 23, 2021
Medicine, Clinical medicine, Medical specialties, Membrane technology, Renal dialysis, Kidney diseases, Hemodialysis, Dialysis, Vascular access, Vascular surgery, Stent, Chronic kidney disease

The product is aimed to eliminate vascular surgery failures, at first targeting vascular access surgery required to initiate hemodialysis treatment for end-stage renal disease (ESRD) patients.

Key Points: 
  • The product is aimed to eliminate vascular surgery failures, at first targeting vascular access surgery required to initiate hemodialysis treatment for end-stage renal disease (ESRD) patients.
  • Our bioengineered solution has the potential to transform the lives of these patients," said Tim Boire, Ph.D., VenoStent's Co-Founder and CEO.
  • However, dialysis itself is not without difficulties: vascular access surgery required to initiate hemodialysis have a 55-65% failure rate.
  • Its first product, SelfWrap, is a slip-on, bioresorbable wrap aimed to eliminate vascular access surgery failure rate of 55-65% in hemodialysis patients.

Global Hemodialysis and Peritoneal Dialysis Market (2020 to 2027) - by Product, Type, and End-user - ResearchAndMarkets.com

Retrieved on: 
Monday, February 22, 2021
Health, Medical Supplies, Medical devices, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Dialysis, Hemodialysis, Peritoneal dialysis, Northwest Kidney Centers, Kt/V

The "Hemodialysis and Peritoneal Dialysis Market by Product, Type, and End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis and Peritoneal Dialysis Market by Product, Type, and End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Based on the peritoneal dialysis product type, the consumables segment is estimated to account for the largest share of this market in 2020.
  • The large share of this segment is mainly attributed to the requirement of peritoneal dialysis consumables for both types of peritoneal dialysis.
  • North America is estimated to command the largest share of the hemodialysis and peritoneal dialysis market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis

Retrieved on: 
Tuesday, February 9, 2021
Membrane technology, Medicine, Chemistry, Physical sciences, Renal dialysis, Rockwell Medical, Hemodialysis, Dialysis, Iron deficiency, Iron

Triferic is a novel, physiologic iron maintenance therapy that provides bioavailable iron to replace iron lost during every dialysis treatment and maintain hemoglobin.

Key Points: 
  • Triferic is a novel, physiologic iron maintenance therapy that provides bioavailable iron to replace iron lost during every dialysis treatment and maintain hemoglobin.
  • Triferic Dialysate and Triferic AVNU are the only FDA-approved therapies in the U.S. indicated to replace iron and maintain hemoglobin in hemodialysis patients during each dialysis treatment.
  • Triferic and Triferic AVNU address a significant medical need in treating functional iron deficiency in end-stage kidney disease patients.
  • Triferic is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office.

Global Dialysis Market Analysis and Industry Forecast to 2030: Hemodialysis and Peritoneal Dialysis & Equipment, Consumables, Dialysis Drugs and Services

Retrieved on: 
Thursday, February 4, 2021
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Dialysis, Peritoneal dialysis, Hemodialysis, Northwest Kidney Centers

DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2018 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2018 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Hemodialysis includes extra-corporeal purification of blood, while peritoneal dialysis includes blood purification methods using peritoneum a patient's abdomen for dialysis.
  • Rising patient pool around the world is boosting the growth of the global dialysis market.
  • However, risks & complications associated with dialysis and product recall are impeding the dialysis market growth.

Hemodialysis and Peritoneal Dialysis Market to Reach $22.16 Bn, Globally, by 2027 at 6.0% CAGR: Allied Market Research

Retrieved on: 
Wednesday, February 3, 2021
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Detoxification, Dialysis, Hemodialysis, Home hemodialysis, Peritoneal dialysis, Northwest Kidney Centers

PORTLAND, Ore., Feb. 3, 2021 /PRNewswire/ -- Allied Market Research published a report titled," Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027."

Key Points: 
  • PORTLAND, Ore., Feb. 3, 2021 /PRNewswire/ -- Allied Market Research published a report titled," Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 20202027."
  • However, major surgeries such as kidney transplants were postponed during the first phase of the lockdown, thereby influencing the hemodialysis and peritoneal dialysis market to certain extent.
  • Based on product, the consumables segment accounted for 92% of the global hemodialysis and peritoneal dialysis market revenue in 2019, and is expected to lead the trail by 2027.
  • Based on geography, Asia-Pacific, followed by North America, held the largest share in 2019, garnering more than two-fifths of the global hemodialysis and peritoneal dialysis market.

Hemodialysis and Peritoneal Dialysis Market to Reach $22.16 Bn, Globally, by 2027 at 6.0% CAGR: Allied Market Research

Retrieved on: 
Wednesday, February 3, 2021
Clinical medicine, Medicine, Renal dialysis, Membrane technology, Detoxification, Dialysis, Peritoneal dialysis, Hemodialysis, Kidney transplantation, Nephrology, Northwest Kidney Centers

The global hemodialysis and peritoneal dialysis market has not been much affected by the outbreak of covid-19, since the rules and regulations pertaining to pandemic have not been imposed on the healthcare sector.

Key Points: 
  • The global hemodialysis and peritoneal dialysis market has not been much affected by the outbreak of covid-19, since the rules and regulations pertaining to pandemic have not been imposed on the healthcare sector.
  • However, major surgeries such as kidney transplants were postponed during the first phase of the lockdown, thereby influencing the hemodialysis and peritoneal dialysis market to certain extent.
  • Based on product, the consumables segment accounted for 92% of the global hemodialysis and peritoneal dialysis market revenue in 2019, and is expected to lead the trail by 2027.
  • Based on geography, Asia-Pacific, followed by North America, held the largest share in 2019, garnering more than two-fifths of the global hemodialysis and peritoneal dialysis market.

$145 Billion Dialysis Market by Dialysis Type, Products & Services, & End User - Global Opportunity Analysis and Industry Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 3, 2021
General Health, Health, Medical devices, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Dialysis, Hemodialysis, Peritoneal dialysis

The "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2018 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2018 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The Global Dialysis Market was valued at USD 96.25 billion in 2019 and is anticipated to garner USD 145.85 billion by 2030 at a CAGR of 3.8% during the forecast period from 2020 to 2030.
  • Hemodialysis includes extra-corporeal purification of blood, while peritoneal dialysis includes blood purification methods using peritoneum a patient's abdomen for dialysis.
  • Rising patient pool around the world is boosting the growth of the global dialysis market.

Okayama University research: Plates and belts -- a toolkit to prevent accidental falls during invasive vascular procedures

Retrieved on: 
Friday, January 22, 2021
Organic polymers, Chemistry, Membrane technology, Physical sciences, Commodity chemicals, Dielectrics, Plastics, Thermoplastics, Hemodialysis, Dialysis, Polypropylene, Polyvinyl chloride

The vascular-access intervention assistance plate as the innovators named it is constructed from a durable and cost-effective polymer called polypropylene.

Key Points: 
  • The vascular-access intervention assistance plate as the innovators named it is constructed from a durable and cost-effective polymer called polypropylene.
  • "The vascular-access intervention assistance plate provides good operability and safety, preventing accidental falls in patients undergoing hemodialysis or other procedures," summarizes the research team.
  • Containing accidental falls is key to preventing further complications in patients undergoing hemodialysis, who are often severely ill and/or old.
  • New Vascular-Access Intervention Assistance Plate Provides Good Operability and Safety by Preventing Accidental Falls:First Experience of 1,872 Cases.

Okayama University research: Plates and belts -- a toolkit to prevent accidental falls during invasive vascular procedures

Retrieved on: 
Friday, January 22, 2021
Organic polymers, Chemistry, Membrane technology, Physical sciences, Commodity chemicals, Dielectrics, Plastics, Thermoplastics, Hemodialysis, Dialysis, Polypropylene, Polyvinyl chloride

The vascular-access intervention assistance plate as the innovators named it is constructed from a durable and cost-effective polymer called polypropylene.

Key Points: 
  • The vascular-access intervention assistance plate as the innovators named it is constructed from a durable and cost-effective polymer called polypropylene.
  • "The vascular-access intervention assistance plate provides good operability and safety, preventing accidental falls in patients undergoing hemodialysis or other procedures," summarizes the research team.
  • Containing accidental falls is key to preventing further complications in patients undergoing hemodialysis, who are often severely ill and/or old.
  • New Vascular-Access Intervention Assistance Plate Provides Good Operability and Safety by Preventing Accidental Falls:First Experience of 1,872 Cases.